Corbus Pharmaceuticals still shows promise, with CRB-701 and CRB-601 advancing in clinical trials. Read why CRBP stock is ...
Bitcoin has surged past the US$80,000 mark for the first time, reaching A$122,894 on Sunday. This historic high comes as ...
Click here for an analysis of Cartesian Therapeutics' recent stock rebound and RNA cell therapy assets, including mixed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback